Biochemical and Pharmacological Characterization of Serotonin‐O‐Carboxymethylglycyl[125I]Iodotyrosinamide5 a New Radioiodinated Probe for 5‐HT1B and 5‐HT1D Binding Sites
暂无分享,去创建一个
J. Chauveau | P. Boulenguez | M. Delaage | J. Lanoir | A. Morel | L. Ségu
[1] J. Chauveau,et al. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites. , 1991, The Journal of pharmacology and experimental therapeutics.
[2] J. Chauveau,et al. A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sites. , 1991, European journal of pharmacology.
[3] R. Glennon,et al. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.
[4] P. Rage,et al. A new system for computer-assisted quantitative receptor autoradiography , 1990, Journal of Neuroscience Methods.
[5] S. Peroutka,et al. 5‐Hydroxytryptamine receptor “families” , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] M. J. Sumner,et al. 5‐HT1D binding sites in porcine brain can be sub‐divided by GR43175 , 1989, British journal of pharmacology.
[7] M. Titeler,et al. Detection of a Novel Serotonin Receptor Subtype (5‐HT1E) in Human Brain: Interaction with a GTP‐Binding Protein , 1989, Journal of neurochemistry.
[8] D. Middlemiss,et al. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. , 1989, Trends in pharmacological sciences.
[9] D. E. Nichols,et al. Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand , 1989, Brain Research.
[10] J. Bockaert,et al. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. , 1988, Molecular pharmacology.
[11] M. Titeler,et al. Detection and Characterization of the Serotonin 5‐HT1D Receptor in Rat and Human Brain , 1988 .
[12] J. Palacios,et al. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites , 1988, Neuroscience Letters.
[13] M. Hamon,et al. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies. , 1988, The Journal of pharmacology and experimental therapeutics.
[14] Gavin Kilpatrick,et al. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.
[15] R. Ciaranello,et al. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states. , 1987, The Journal of pharmacology and experimental therapeutics.
[16] R. Glennon,et al. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. , 1987, Biochemical pharmacology.
[17] S. Peroutka,et al. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[18] B. Hoffman,et al. N1‐Methyl‐2‐125I‐Lysergic Acid Diethylamide, a Preferred Ligand for In Vitro and In Vivo Characterization of Serotonin Receptors , 1987, Journal of neurochemistry.
[19] P. Conn,et al. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Peroutka,et al. Species variations in RU 24969 interactions with non-5-HT1A binding sites. , 1986, European journal of pharmacology.
[21] J. Shih,et al. [3H]1‐[2‐(4‐Aminophenyl)Ethyl]‐4‐(3‐Trifluoromethylphenyl)Piperazine: A Selective Radioligand for 5‐HT1A Receptors in Rat Brain , 1986, Journal of neurochemistry.
[22] D. Hoyer,et al. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. , 1985, European journal of pharmacology.
[23] D. Hoyer,et al. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.
[24] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[25] J. Palacios,et al. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.
[26] J. Glowinski,et al. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.
[27] P. Molinoff,et al. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. , 1981, Life sciences.
[28] H. Yamamura,et al. Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.
[29] S H Snyder,et al. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.